SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16. (U.S. $30.4MM, +1%, ex-U.S. $3.8MM, +0.2%)
Based on SeaSpine’s estimates, quarterly and 1H17 revenues by segment are expected to approximate the following:
2Q17 | 2Q16 | $ Change | % Change | |
Spine | $16.6 | $16.4 | $0.2 | 1.2% |
Orthobiologics | $17.6 | $16.8 | $0.8 | 4.7% |
Total | $34.2 | $33.2 | $1.0 | 3.0% |
1H17 | 1H16 | $ Change | % Change | |
Spine | $31.4 | $31.1 | $0.2 | 0.7% |
Orthobiologics | $34.7 | $33.5 | $1.3 | 3.8% |
Total | $66.1 | $64.6 | $1.5 | 2.3% |
The company’s recent completion of full commercial launch of its Mariner Posterior Fixation system reflects its continuing focus on expanding its product portfolio.
Sources: SeaSpine; ORTHOWORLD Inc.
SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16. (U.S. $30.4MM, +1%, ex-U.S. $3.8MM, +0.2%)
Based on SeaSpine's estimates, quarterly and 1H17 revenues by segment are expected to approximate the following:
Q17
Q16
$...
SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16. (U.S. $30.4MM, +1%, ex-U.S. $3.8MM, +0.2%)
Based on SeaSpine’s estimates, quarterly and 1H17 revenues by segment are expected to approximate the following:
2Q17 | 2Q16 | $ Change | % Change | |
Spine | $16.6 | $16.4 | $0.2 | 1.2% |
Orthobiologics | $17.6 | $16.8 | $0.8 | 4.7% |
Total | $34.2 | $33.2 | $1.0 | 3.0% |
1H17 | 1H16 | $ Change | % Change | |
Spine | $31.4 | $31.1 | $0.2 | 0.7% |
Orthobiologics | $34.7 | $33.5 | $1.3 | 3.8% |
Total | $66.1 | $64.6 | $1.5 | 2.3% |
The company’s recent completion of full commercial launch of its Mariner Posterior Fixation system reflects its continuing focus on expanding its product portfolio.
Sources: SeaSpine; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.